How Often Do You Take Wegovy? Understanding the Dosing Schedule for Effective Weight Management

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections are administered once per week in a structured escalation protocol designed to minimize side effects while building tolerance. Clinical trials show that patients who follow the full 16-week titration schedule achieve an average weight loss of 10–15% of body weight by week 20. Understanding your dosing timeline helps you set realistic expectations and stay committed to the treatment plan.

Weekly Semaglutide Injection Dosing Schedule

Semaglutide injections follow a proven step-up protocol that takes approximately 4 months to complete. You begin at 0.25 mg once weekly for 4 weeks, then increase to 0.5 mg weekly for the next month. The schedule continues with 1 mg weekly for another 4 weeks, followed by 1.7 mg weekly, and finally stabilizing at 2.4 mg weekly as your maintenance dose. Each weekly injection is self-administered subcutaneously using a pre-filled pen into your abdomen, thigh, or upper arm.

This gradual escalation strategy allows your gastrointestinal system to adapt to the medication, reducing nausea and other adjustment-related side effects. Most patients report that early weeks involve mild appetite suppression, which intensifies as doses increase over the titration phase. Your provider may extend the timeline between dose increases if you experience significant discomfort, or may pause progression while your body acclimates to each level.

Why Weekly Injections Outperform Daily Dosing

The once-weekly injection format delivers semaglutide in a sustained-release formulation that maintains consistent blood levels throughout the week, eliminating the need for daily dosing compliance. Research shows that weekly administration improves medication adherence by up to 85% compared to daily oral formulations, because patients experience fewer "doses to remember." This simplified schedule fits naturally into most routines—many patients inject on the same day each week, such as Sunday morning.

Weekly semaglutide also produces more stable glucose control and appetite suppression than daily alternatives, because the medication concentration rises gradually and plateaus predictably. This steady-state effect means fewer fluctuations in hunger cues and energy levels throughout the week. Patients report that once-weekly dosing feels less burdensome than daily medication schedules, which increases long-term treatment persistence.

How Long Until Semaglutide Reaches Full Effectiveness

Significant weight loss typically becomes noticeable between weeks 8 and 12, as your dose reaches the 1–1.7 mg range during the titration phase. Most patients lose 3–5 pounds during the first 4 weeks, then experience accelerating weight loss as their maintenance dose approaches. By week 16 when you reach the 2.4 mg target, your appetite suppression and metabolic effects are working at peak capacity, often resulting in 1–2 pounds of weekly loss.

Full clinical benefit takes time because your body is adjusting to a new metabolic set point and sustainable eating patterns. The 16-week titration window allows your brain to respond to GLP-1 receptor activation, your gut hormones to recalibrate, and your satiety signals to reset. Many patients continue losing weight even after reaching their maintenance dose, because the cumulative metabolic changes deepen over months 5–6 of treatment.

PlexusDx Compounded Semaglutide: Same Schedule, Personalized Support

PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies across all 50 states, following the same evidence-based weekly dosing schedule as brand-name versions. Your treatment begins at $149 per month flat—that price does not change as your dose increases during titration. This transparent pricing model eliminates hidden costs and dose-based surcharges that typical weight-loss clinics charge.

PlexusDx offers optional Precision Peptide Genetic Testing ($99 add-on after your first month) to identify your genetic predisposition across 14 pathways and 49 peptides, including key variants like GLP1R rs6923761 and GIPR rs1800437. These insights help your provider anticipate your likely response to semaglutide and adjust your titration timeline for optimal results. HSA and FSA accounts qualify, making compounded semaglutide accessible without insurance.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I inject semaglutide every day or once a week?

Semaglutide is injected once per week on a fixed schedule. You follow a 16-week titration phase starting at 0.25 mg and increasing every 4 weeks until reaching your 2.4 mg maintenance dose. This once-weekly format improves adherence and maintains stable appetite suppression throughout the week.

When will I start losing weight on the semaglutide dosing schedule?

Most patients notice appetite suppression within the first 2–3 weeks at the 0.25 mg dose, with measurable weight loss appearing between weeks 8–12 as doses escalate. Peak weight-loss results occur once you reach your 2.4 mg maintenance dose around week 16, with continued loss accelerating through months 4–6 of treatment.

What if my dose needs to increase—will my PlexusDx price go up?

No. PlexusDx compounded semaglutide starts at $149 per month and remains flat across all dose levels during your titration schedule and maintenance phase. Your dose may increase, but your price stays the same—this is PlexusDx's core pricing promise.

Can I skip a weekly injection or adjust my dosing schedule?

Never skip a scheduled injection without consulting your provider, because inconsistent dosing breaks the escalation protocol and reduces appetite-suppression effectiveness. If you experience side effects or life circumstances require a pause, contact your PlexusDx provider to safely adjust timing rather than stopping abruptly.

How does the Precision Peptide Genetic Test relate to my semaglutide dosing?

The PlexusDx Precision Peptide Genetic Test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, which predict how your body responds to semaglutide at each dose level. This $99 add-on after your first month helps your provider customize your titration pace and anticipate your weight-loss potential, ensuring your 16-week schedule is optimized for your unique biology.

Related Reading

• Wegovy For Losing Weight
• Wegovy For Weight Loss 2
• Wegovy Providers That Take Fsa Plexusdx
• Tirzepatide Dosing Schedule Plexusdx

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.